The group of experts learned that will influence the choice of drugs for appointments in American hospitals. As it turned out, financial incentives from the pharmaceutical companies – one of the main motivations to designate the specific medication with the trade name.
According to the statistics database on the Medicare prescription statins and the doctors receiving remuneration from pharmaceutical companies for 2011, approximately 37% of doctors receive incentives from drug manufacturers, if prescribed it to their patients. 71% as a bonus receive free lunch at the expense of the company, half of the additionally write grants.
The drugs with the trade name "motivated" doctors discharged at 22.8% of cases, and "unmotivated" - 17.8% of cases. The scientists concluded: if a pharmaceutical company engaged in politics promote their funds through doctors, its profit from sales increased by 4.8%.